CIUSSS Saguenay Lac-St-Jean
Chicoutimi, Quebec G7H5H6
0 studies enrolling now · 3 studies all time
What they study most
Acute Non-cardioembolic Ischemic Stroke, Atrial Fibrillation, Congestive Heart Failure, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism
Studies at this site
- Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure — Running, not enrolling
- A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
- A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early